SWX/CURN (SWX/CURN)

SIX Swiss Exchange: SWX/CURN · CHF

CHF 18.8

+1.75 (+10.3%)· Recorded snapshot

Market cap	99.9M
Revenue (ttm)	13.5M
Net income (ttm)	-658K
EPS (ttm)	-CHF 0.13
Shares out	5.3M
Volume	341
Beta	-0.71

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 13.5M
Net income (ttm): -658K
EPS (ttm): -CHF 0.13
Market cap: 99.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1.4

P25 n/aP50 n/aP75 n/a

ROIC-0.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/CURN indicators

Market & fundamental data

Available fields

163

Groups with data

Currency

CHF

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	Switzerland
Country code	CH
Earnings date	2026-12-22
Employees	9
Enterprise value	CHF 96.3M
Exchange	SIX Swiss Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2002
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CH1330780979
Last earnings date	2026-09-21
Last refreshed	2026-11-03
Market cap	CHF 99.9M
Next earnings date	2026-12-22
Price	CHF 18.80
Price currency	CHF
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-02
Symbol	swx/CURN
Website	https://curatis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.69%
EV/Sales	7.13x
Industry P/E	60.61x
P/B ratio	2.05x
P/S ratio	7.4x
Sector forward P/E	19.93x
Sector P/E	34.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.85%
EBITDA margin	-2.01%
Gross margin	24.13%
Operating margin	-4.85%
Pretax margin	-4.69%
Profit margin	-4.88%
Profit per employee	CHF -73,111
Revenue per employee	CHF 1.5M
ROA	-0.73%
ROCE	-1.18%
ROE	-1.41%
ROIC	-0.88%
SBC / revenue	1%
Tax / revenue	0.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	5
EPS growth years	3
Gross profit growth	32.88%
Gross profit growth (Q)	32.12%
Net income growth quarters	4
Net income growth years	2
Revenue growth	32.84%
Revenue growth (Q)	51.44%
Revenue growth (QoQ)	42.88%
Revenue growth quarters	3
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CHF 383,000
EBIT	CHF -654,000
EBITDA	CHF -271,000
EPS	CHF -0.13
Financing cash flow	CHF 4.3M
Gross profit	CHF 3.3M
Income taxes	CHF 25,000
Investing cash flow	CHF -1.6M
Net cash flow	CHF 1.6M
Net income	CHF -658,000
Operating cash flow minus SBC	CHF -1.3M
Operating income	CHF -654,000
Revenue	CHF 13.5M
Stock-based compensation	CHF 135,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.1
Book value per share	CHF 9.39
Debt / equity	0
Interest coverage	-40.88
Long-term assets	CHF 50.7M
Long-term liabilities	CHF 6.5M
Net cash (debt)	CHF 3.6M
Net cash / market cap	3.6%
Net cash growth	75.79%
Net debt / equity	-0.07
Piotroski F-Score	3
Shareholders' equity	CHF 48.8M
Tangible book value	CHF -1.7M
Tangible book value per share	CHF -0.32
Total assets	CHF 57.9M
Total cash	CHF 3.6M
Total debt	CHF 0
Total liabilities	CHF 9.1M
WACC	0.37%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.24
Current assets	CHF 7.2M
Current liabilities	CHF 2.6M
Current ratio	2.79
Inventory turnover	6.67
Net working capital	CHF 1M
Quick ratio	2.12
Working capital	CHF 4.6M
Working capital turnover	4.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-60.46%
Shareholder yield	-60.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CHF 21.31
1D price change	10.26%
1M price change	5.92%
1M total return	5.92%
1W price change	7.74%
1W total return	7.74%
1Y price change	48.03%
1Y return CAGR	48.07%
1Y total return	48.03%
20-day SMA	CHF 17.79
200-day SMA	CHF 20.69
3M price change	-7.84%
3M total return	-7.84%
50-day SMA	CHF 18.61
50-day SMA vs 200-day SMA	50under200
52-week high	CHF 27.90
52-week high date	2026-03-11
52-week low	CHF 11.05
52-week low date	2025-12-22
6M price change	-22.95%
6M total return	-22.95%
All-time high	CHF 27.90
All-time high date	2026-03-11
All-time low	CHF 5.00
All-time low date	2024-08-22
Average true range (ATR)	CHF 0.94
Average volume	1.4K
Beta (1Y)	0.03
Beta (2Y)	-0.31
Beta (5Y)	-0.71
Change from 52-week high	-32.62%
Change from 52-week low	70.14%
Change from all-time high	-32.62%
Change from all-time low	276%
Change from open	10.26%
Day's gap	0%
Dollar volume	CHF 6,411
High price	CHF 18.80
Low price	CHF 17.05
Monthly RSI	52.67
Open price	CHF 17.05
Position in 52-week range	100%
Previous close	CHF 17.05
Price vs 150-day SMA	-11.77%
Price vs 20-day SMA	5.67%
Price vs 200-day SMA	-9.12%
Price vs 50-day SMA	1%
Relative volume	0.24
RSI	55.41
Sharpe ratio	0.73
Sortino ratio	1.51
Volume	341
Weekly RSI	47.65
YTD price change	56.67%
YTD total return	56.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.2M
Shares change (QoQ)	3.38%
Shares change (YoY)	60.46%
Shares held by insiders	77.91%
Shares held by institutions	4.26%
Shares outstanding	5.3M

Deeper analysis on SWX/CURN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/CURN report

Is a complete SWX/CURN research report available?

No complete published report is available for swx/CURN (SWX/CURN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/CURN (SWX/CURN)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/CURN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/CURN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/CURN

Frequently asked questions